Literature DB >> 21821704

Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiation.

Shannon P Hilchey1, Alexander F Rosenberg, Ollivier Hyrien, Shelley Secor-Socha, Matthew R Cochran, Michael T Brady, Jyh-Chiang E Wang, Iñaki Sanz, W Richard Burack, Sally A Quataert, Steven H Bernstein.   

Abstract

The follicular lymphoma (FL) T-cell microenvironment plays a critical role in the biology of this disease. We therefore determined the lineage, differentiation state, and functional potential of FL-infiltrating CD4(+) T-helper cells (T(H)) compared with reactive and normal lymph node (NLN) T(H) cells. Relative to NLNs, FL cells have decreased proportions of naive and central memory but increased proportions of effector memory T(H) cells. We further show differences in the distribution and anatomical localization of CXCR5(+) T(H) populations that, on the basis of transcription factor analysis, include both regulatory and follicular helper T cells. On Staphylococcus enterotoxin-B stimulation, which stimulates T cells through the T-cell receptor, requires no processing by APCs, and can overcome regulator T cell-mediated suppression, the proportion of uncommitted primed precursor cells, as well as T(H)2 and T(H)17 cells is higher in FL cells than in reactive lymph nodes or NLNs. However, the proportion of T(H)1 and polyfunctional T(H) cells (producing multiple cytokines simultaneously) is similar in FL cells and NLNs. These data suggest that, although T(H)-cell differentiation in FL is skewed compared with NLNs, FL T(H) cells should have the same intrinsic ability to elicit antitumor effector responses as NLN T(H) cells when tumor suppressive mechanisms are attenuated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821704      PMCID: PMC3186335          DOI: 10.1182/blood-2011-03-340646

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

Review 1.  Implications of the tumor microenvironment on survival and disease response in follicular lymphoma.

Authors:  John G Gribben
Journal:  Curr Opin Oncol       Date:  2010-09       Impact factor: 3.645

Review 2.  Prognostic factors in follicular lymphoma.

Authors:  Thomas Relander; Nathalie A Johnson; Pedro Farinha; Joseph M Connors; Laurie H Sehn; Randy D Gascoyne
Journal:  J Clin Oncol       Date:  2010-04-12       Impact factor: 44.544

3.  Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment.

Authors:  Andrew J Clear; Abigail M Lee; Maria Calaminici; Alan G Ramsay; Kelly J Morris; Simon Hallam; Gavin Kelly; Finlay Macdougall; T Andrew Lister; John G Gribben
Journal:  Blood       Date:  2010-04-07       Impact factor: 22.113

Review 4.  Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.

Authors:  Laetitia Aymeric; Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Isabelle Martins; Guido Kroemer; Mark J Smyth; Laurence Zitvogel
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

5.  Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation.

Authors:  Robert J Johnston; Amanda C Poholek; Daniel DiToro; Isharat Yusuf; Danelle Eto; Burton Barnett; Alexander L Dent; Joe Craft; Shane Crotty
Journal:  Science       Date:  2009-07-16       Impact factor: 47.728

6.  Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy.

Authors:  Alan G Ramsay; Andrew J Clear; Gavin Kelly; Rewas Fatah; Janet Matthews; Finlay Macdougall; T Andrew Lister; Abigail M Lee; Maria Calaminici; John G Gribben
Journal:  Blood       Date:  2009-09-28       Impact factor: 22.113

7.  Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.

Authors:  Shannon P Hilchey; James J Kobie; Mathew R Cochran; Shelley Secor-Socha; Jyh-Chiang E Wang; Ollivier Hyrien; W Richard Burack; Tim R Mosmann; Sally A Quataert; Steven H Bernstein
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

8.  Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.

Authors:  Ilona Kryczek; Mousumi Banerjee; Pui Cheng; Linhua Vatan; Wojciech Szeliga; Shuang Wei; Emina Huang; Emily Finlayson; Diane Simeone; Theodore H Welling; Alfred Chang; George Coukos; Rebecca Liu; Weiping Zou
Journal:  Blood       Date:  2009-05-21       Impact factor: 22.113

9.  A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages.

Authors:  Björn Engelbrekt Wahlin; Mohit Aggarwal; Santiago Montes-Moreno; Luis Francisco Gonzalez; Giovanna Roncador; Lidia Sanchez-Verde; Birger Christensson; Birgitta Sander; Eva Kimby
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

10.  CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.

Authors:  Jean M Fletcher; Roisin Lonergan; Lisa Costelloe; Katie Kinsella; Barry Moran; Cliona O'Farrelly; Niall Tubridy; Kingston H G Mills
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

View more
  13 in total

Review 1.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

2.  High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells.

Authors:  June H Myklebust; Jonathan M Irish; Joshua Brody; Debra K Czerwinski; Roch Houot; Holbrook E Kohrt; John Timmerman; Jonathan Said; Michael R Green; Jan Delabie; Arne Kolstad; Ash A Alizadeh; Ronald Levy
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

3.  CD10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells.

Authors:  Patricia Amé-Thomas; Sylvia Hoeller; Catherine Artchounin; Jan Misiak; Mounia Sabrina Braza; Rachel Jean; Jérôme Le Priol; Céline Monvoisin; Nadine Martin; Philippe Gaulard; Karin Tarte
Journal:  Blood       Date:  2015-03-02       Impact factor: 22.113

4.  Entourage: the immune microenvironment following follicular lymphoma.

Authors:  B E Wahlin; B Sander; B Christensson; B Ostenstad; H Holte; P D Brown; C Sundström; E Kimby
Journal:  Blood Cancer J       Date:  2012-01-20       Impact factor: 11.037

5.  Neuroantigen-Specific CD4 Cells Expressing Interferon-γ (IFN-γ), Interleukin (IL)-2 and IL-3 in a Mutually Exclusive Manner Prevail in Experimental Allergic Encephalomyelitis (EAE).

Authors:  Alexey Y Karulin; Stefan Quast; Maike D Hesse; Paul V Lehmann
Journal:  Cells       Date:  2012-08-24       Impact factor: 6.600

Review 6.  The Tumor Microenvironment in Follicular Lymphoma: Its Pro-Malignancy Role with Therapeutic Potential.

Authors:  Takashi Watanabe
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

Review 7.  Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients.

Authors:  Franz Buchegger; Steven M Larson; Jean-Pierre Mach; Yves Chalandon; Pierre-Yves Dietrich; Anne Cairoli; John O Prior; Pedro Romero; Daniel E Speiser
Journal:  Clin Dev Immunol       Date:  2013-11-26

8.  Mesenchymal stromal cells support the viability and differentiation of follicular lymphoma-infiltrating follicular helper T-cells.

Authors:  Michael T Brady; Shannon P Hilchey; Ollivier Hyrien; Stephen A Spence; Steven H Bernstein
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

9.  Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node.

Authors:  Hristina Nedelkovska; Alexander F Rosenberg; Shannon P Hilchey; Ollivier Hyrien; W Richard Burack; Sally A Quataert; Christina M Baker; Mitra Azadniv; Stephen L Welle; Stephen M Ansell; Minsoo Kim; Steven H Bernstein
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

Review 10.  T follicular helper cells: a potential therapeutic target in follicular lymphoma.

Authors:  Jordi Ochando; Mounia S Braza
Journal:  Oncotarget       Date:  2017-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.